earnings
NR
NASDAQ · NRSN
NeuroSense Therapeutics Ltd. Ordinary Shares
Healthcare · Biotechnology
$1.99
Down-$0.14 (-6.57%)
Updated Nov 1, 2026, 8:11 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 21.85M
- P/E ratio
- -2.6
- Dividend yield
- 0.00%
- 52-week range
- $0.25 – $10.33
- Volume
- 20.18K
- Avg. volume
- 631.27K
Price performance · NRSN
NRSN price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NRSN closed at $1.99 after 20 trading sessions, down 50.62% for the selected period.
- Last close
- $1.99
- Period change
- -50.62%
- Period low
- $1.99
- Period high
- $4.07
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $2.20 | $2.22 | $1.99 | $1.99 | 20.18K |
| Oct 29, 2026 | $2.302 | $2.32 | $2.0902 | $2.13 | 20.58K |
| Oct 28, 2026 | $2.33 | $2.37 | $2.20 | $2.36 | 17.3K |
| Oct 27, 2026 | $2.30 | $2.5999 | $2.28 | $2.37 | 22.27K |
| Oct 26, 2026 | $2.4664 | $2.75 | $2.31 | $2.33 | 29.71K |
| Oct 23, 2026 | $2.49 | $2.55 | $2.40 | $2.46 | 11.15K |
| Oct 22, 2026 | $2.55 | $2.5699 | $2.15 | $2.44 | 18.6K |
| Oct 21, 2026 | $2.46 | $2.70 | $2.4101 | $2.56 | 11.27K |
| Oct 20, 2026 | $2.74 | $2.74 | $2.19 | $2.39 | 13.85K |
| Oct 19, 2026 | $2.94 | $2.94 | $2.3586 | $2.665 | 117.6K |
| Oct 16, 2026 | $3.06 | $3.24 | $3.06 | $3.07 | 9.7K |
| Oct 15, 2026 | $3.08 | $3.2608 | $2.87 | $3.17 | 11.86K |
| Oct 14, 2026 | $3.56 | $3.60 | $3.05 | $3.06 | 30.84K |
| Oct 13, 2026 | $3.7744 | $3.784 | $3.365 | $3.49 | 43.22K |
| Oct 12, 2026 | $3.66 | $3.66 | $3.28 | $3.48 | 7.42K |
| Oct 9, 2026 | $3.6135 | $3.85 | $3.6135 | $3.66 | 15.61K |
| Oct 8, 2026 | $3.82 | $3.8979 | $3.561 | $3.58 | 15.85K |
| Oct 7, 2026 | $3.95 | $4.07 | $3.79 | $3.82 | 12.89K |
| Oct 6, 2026 | $4.03 | $4.33 | $3.94 | $4.07 | 17.78K |
| Oct 5, 2026 | $4.06 | $4.54 | $3.96 | $4.03 | 12.25K |
Latest NRSN news
The latest Smart Investors Daily articles mentioning NRSN.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…